Katherine (k-t) E Varley

Title: Katherine (k-t) E Varley: Innovator in Cancer Risk Assessment

Introduction

Katherine (k-t) E Varley is a notable inventor based in Salt Lake City, UT (US). He has made significant contributions to the field of cancer research, particularly in assessing the risk of cancer recurrence. His innovative work has the potential to impact the lives of many patients facing cancer diagnoses.

Latest Patents

Katherine Varley holds a patent for a multigene assay designed to assess the risk of recurrence of cancer. This patent includes biomarkers and methods for determining the risk of cancer recurrence in a subject. The methods involve determining the level of expression of at least one MHCII gene, assessing the level of expression of at least one TIL gene, and calculating an Immune Activation Score for the subject. Additionally, the patent provides methods for diagnosing a subject with triple-negative breast cancer (TNBC) as having the TNBC Basal-like subtype, along with methods for treating cancer in a subject. He has 1 patent to his name.

Career Highlights

Katherine Varley is associated with the University of Utah Research Foundation, where he continues to advance his research in cancer diagnostics and treatment. His work is characterized by a commitment to improving patient outcomes through innovative scientific methods.

Collaborations

Katherine has collaborated with esteemed colleagues, including Rachel L Stewart and Philip S Bernard, to further enhance the impact of his research in the field of oncology.

Conclusion

Katherine (k-t) E Varley is a pioneering inventor whose work in cancer risk assessment is making strides in the medical field. His contributions are vital for the future of cancer diagnostics and treatment.